as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹60.38
Change
+0.13 (0.22%)
Open
₹60.04
Prev. Close
₹60.25
Day High
₹61.9
Day Low
₹59.82
Volume Analysis
Traded
488,169
Delivered
181,502
Delivery %
37.18%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (0)
No signal for this stock
Opportunities (1)
- •Strong 3-year EPS growth (17.6%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹63.66 | ₹62.78 | ₹61.58 | ₹60.7 | ₹59.5 | ₹58.62 | ₹57.42 |
| Fibonacci | ₹62.78 | ₹61.99 | ₹61.49 | ₹60.7 | ₹59.91 | ₹59.41 | ₹58.62 |
| Camarilla | ₹60.95 | ₹60.76 | ₹60.57 | ₹60.7 | ₹60.19 | ₹60.0 | ₹59.81 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
+0.78%
1 Month
-6.39%
3 Months
-14.0%
6 Months
—
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹16.39
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
19.07%
Net margin 8.86% × asset turnover 1.03x × equity multiplier 2.09x
Company Overview
Sector
Fast Moving Consumer Goods
Market Cap
₹780 Cr
P/E (TTM)
20.4
ROE
17.1%
Book Value
₹19.9
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Hexagon Nutrition Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 58/100. The strongest factor is Financial Strength (100/100), while Cash Flow (1/100) is the weakest area to weigh before deciding. Strong 3-year EPS growth (17.6%).
TopFund Score — Fundamentals Quality
58/100 — AverageData confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Company has a low return on equity of 12.8% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Hexagon Nutrition announced H1 FY27 revenue of ₹214.0 crore and PAT of ₹16.2 crore.
Hexagon Nutrition Limited has informed about copy of Newspaper Publication-Q2 Results.
Board approved Q2/H1 FY27 results and began phased Nashik premix facility decommissioning.
Hexagon Nutrition schedules Q2 & H1 FY27 investor call on 17 November 2026, preponed from 18 November.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 107 | 73 | 95 | 100 | 115 | 104 | 110 |
| Expenses + | 94 | 63 | 83 | 84 | 100 | 93 | 98 |
| Operating Profit | 13 | 10 | 12 | 15 | 15 | 12 | 12 |
| OPM % | 11.88% | 13.79% | 12.85% | 15.35% | 13.09% | 11.25% | 10.93% |
| Other Income + | 1 | 1 | 4 | 2 | 4 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
| Profit before tax | 10 | 8 | 13 | 14 | 15 | 11 | 10 |
| Tax % | 22.63% | 23.73% | 23.99% | 25.18% | 29.36% | 23.87% | 19.51% |
| Net Profit + | 8 | 6 | 10 | 10 | 11 | 8 | 8 |
| EPS in Rs | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Raw PDF | — | — | — | — | — | — | — |
| YoY Sales growth | — | — | — | — | 8 | 43 | 15 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2020 (S) | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales + | 99 | 211 | 271 | 298 | 324 | 380 | 429 |
| Expenses + | 88 | 177 | 235 | 273 | 283 | 327 | 374 |
| Operating Profit | 10 | 34 | 36 | 25 | 41 | 53 | 54 |
| OPM % | 11.0% | 16.0% | 13.0% | 8.0% | 13.0% | 14.0% | 13.0% |
| Other Income + | 1 | 6 | 5 | 7 | 6 | 12 | 10 |
| Interest | 1 | 3 | 2 | 4 | 4 | 4 | 4 |
| Depreciation | 3 | 6 | 7 | 8 | 9 | 10 | 10 |
| Profit before tax | 8 | 31 | 32 | 20 | 34 | 51 | 50 |
| Tax % | 7.0% | 27.0% | 28.0% | 37.0% | 28.0% | 26.0% | — |
| Net Profit + | 7 | 23 | 23 | 12 | 24 | 38 | 38 |
| EPS in Rs | 1 | 2 | 2 | 1 | 2 | 3 | 3 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Sales growth | — | — | 28 | — | 9 | 17 | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2020 (S) | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Reserves | 35 | 127 | 149 | 153 | 183 | 222 | 233 |
| Borrowings + | 26 | 20 | 40 | 49 | 29 | 33 | 40 |
| Other Liabilities + | 24 | 55 | 57 | 38 | 38 | 52 | 73 |
| Total Liabilities | 96 | 214 | 257 | 251 | 261 | 318 | 358 |
| Fixed Assets + | 21 | 51 | 55 | 65 | 64 | 64 | 62 |
| CWIP | 0 | 1 | 7 | 2 | 4 | 3 | 3 |
| Investments | 12 | 18 | 23 | 19 | 34 | 37 | 26 |
| Other Assets + | 62 | 144 | 172 | 164 | 159 | 215 | 267 |
| Total Assets | 96 | 214 | 257 | 251 | 261 | 318 | 358 |
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 12 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2020 (S) | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 10 | 29 | 11 | 23 | 38 | 6 |
| Cash from Investing Activity + | -1 | -9 | -21 | 4 | -23 | -5 |
| Cash from Financing Activity + | -5 | -18 | 16 | -19 | -19 | 0 |
| Net Cash Flow | 5 | 1 | 6 | 8 | -4 | 1 |
| Free Cash Flow | 9 | 21 | -5 | 8 | 29 | -1 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 113 | 109 | 56 | 122 | 117 | 33 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Jun 2026 | Sep 2026 | |
|---|---|---|
| Public | 28.99% | 31.24% |
| Promoters | 64.29% | 64.36% |
| FII | 0.29% | 0.29% |
| DII | 6.42% | 4.12% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Fast Moving Consumer Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Hexagon Nutrition Limited (this stock) | 780 | 20.4 | 3.19 | 17.1% |
| Elitecon International L | 798 | 4.92 | 2.29 | 63.6% |
| Mukka Proteins Limited | 759 | 9.58 | 1.41 | 11.1% |
| Zuari Industries Limited | 751 | 5.82 | 0.18 | 2.71% |
| Vadilal Enterprises Ltd. | 811 | 4266.0 | 201.72 | 4.79% |
| Dwarikesh Sugar Ind Ltd | 814 | — | — | — |
| Kokuyo Camlin Limited | 713 | 47.0 | 2.88 | 6.22% |
Which Mutual Funds Hold Hexagon Nutrition Limited?
Frequently Asked Questions about Hexagon Nutrition Limited
Hexagon Nutrition Limited (HEXAGON) closed at ₹60.38 on NSE on 19 November 2026, up 0.13 (0.22%) from the previous close.
Hexagon Nutrition Limited trades on the NSE (National Stock Exchange of India) under the symbol HEXAGON.
Hexagon Nutrition Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 20.4.
Hexagon Nutrition Limited has a dividend yield of 0.49%.
Hexagon Nutrition Limited's 52-week high is ₹78.7 and its 52-week low is ₹48.0.
Hexagon Nutrition Limited has a market capitalisation of ₹780 crore.
Hexagon Nutrition Limited has a TopFund Quality Score of 58/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Hexagon Nutrition Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.